LNK-01001
- Generic Name
- LNK-01001
A Phase 3 Study of LNK01001 Capsule in Subjects With Moderate to Severe Atopic Dermatitis.
- First Posted Date
- 2024-02-26
- Last Posted Date
- 2024-03-20
- Lead Sponsor
- Lynk Pharmaceuticals Co., Ltd
- Target Recruit Count
- 354
- Registration Number
- NCT06277245
- Locations
- 🇨🇳
Dermatological Hospital of Southern Medical University, Guangzhou, China
A Study of LNK01001 Capsule in Subjects With Active Rheumatoid Arthritis
- First Posted Date
- 2024-02-26
- Last Posted Date
- 2024-03-22
- Lead Sponsor
- Lynk Pharmaceuticals Co., Ltd
- Target Recruit Count
- 430
- Registration Number
- NCT06276998
- Locations
- 🇨🇳
Peking Union Medical College Hospital, Beijing, China
A Study of LNK01001 Capsule in Patients With Ankylosing Spondylitis
- First Posted Date
- 2023-10-17
- Last Posted Date
- 2023-10-27
- Lead Sponsor
- Lynk Pharmaceuticals Co., Ltd
- Target Recruit Count
- 177
- Registration Number
- NCT06085534
- Locations
- 🇨🇳
Peking Union Medical College Hospital, Beijing, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath